Review



proteinchip seldi reader  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Bio-Rad proteinchip seldi reader
    Proteinchip Seldi Reader, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pmc02627917-168-6-9?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    proteinchip seldi reader - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    proteinchip seldi reader  (Bio-Rad)
    90
    Bio-Rad proteinchip seldi reader
    Proteinchip Seldi Reader, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pmc02627917-168-6-9?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    proteinchip seldi reader - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    proteinchip seldi (pbs iic) reader  (Bio-Rad)
    90
    Bio-Rad proteinchip seldi (pbs iic) reader
    Proteinchip Seldi (Pbs Iic) Reader, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pmc02627917-178-8-13?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    proteinchip seldi (pbs iic) reader - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    seldi‐tof proteinchip reader  (Ciphergen inc)
    90
    Ciphergen inc seldi‐tof proteinchip reader
    Comparison of human tear proteome studies concerning patients affected by ocular diseases
    Seldi‐Tof Proteinchip Reader, supplied by Ciphergen inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pmc09543345-11-29-30?v=Ciphergen+inc
    Average 90 stars, based on 1 article reviews
    seldi‐tof proteinchip reader - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    seldi‐tof proteinchip reader pbs ii  (Ciphergen inc)
    90
    Ciphergen inc seldi‐tof proteinchip reader pbs ii
    Comparison of human tear proteome studies concerning patients affected by ocular diseases
    Seldi‐Tof Proteinchip Reader Pbs Ii, supplied by Ciphergen inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pmc09543345-20-30-31?v=Ciphergen+inc
    Average 90 stars, based on 1 article reviews
    seldi‐tof proteinchip reader pbs ii - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    series 4000 proteinchip seldi reader  (Bio-Rad)
    90
    Bio-Rad series 4000 proteinchip seldi reader
    Comparison of human tear proteome studies concerning patients affected by ocular diseases
    Series 4000 Proteinchip Seldi Reader, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/us10712350-174-7-12?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    series 4000 proteinchip seldi reader - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    proteinchip® seldi-tof reader pcs4000 ms-tof enterprise  (Bio-Rad)
    90
    Bio-Rad proteinchip® seldi-tof reader pcs4000 ms-tof enterprise
    Progression of specific intensity peaks within mass profiles during Etanercept treatment. Shown is the progression of intensities (relative units) of the 4326 Da (A), 6632 Da (B) and 133977 Da (C) peaks of the mass profiles over time. W0, W12 and W24 correspond to duration of Etanercept treatment expressed in weeks. Samples exhibiting a significant difference for C (healthy controls) vs W0, W0 vs W12 and W0 vs W24 are shown. Horizontal lines correspond to the mean of the 10 samples for each condition. P-values were calculated using the non-parametric Mann-Whitney test when comparing C to W0 (unpaired data), and the non-parametric Wilcoxon signed-rank test when comparing W0 to W12, or W0 to W24 (paired data). *Statistically significant difference between C and W0. **Statistically significant difference between W0 and W12, or between W0 and W24. The 4.3 and 134 kDa masses were detected using fraction 2, and the 6.6 kDa mass was detected using fraction 4. <t>ProteinChip®,</t> matrix and laser intensity conditions are detailed in Table 2.
    Proteinchip® Seldi Tof Reader Pcs4000 Ms Tof Enterprise, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pmc06325504-130-6-12?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    proteinchip® seldi-tof reader pcs4000 ms-tof enterprise - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    proteinchip® seldi reader pcs4000 ms-tof enterprise  (Bio-Rad)
    90
    Bio-Rad proteinchip® seldi reader pcs4000 ms-tof enterprise
    Progression of specific intensity peaks within mass profiles during Etanercept treatment. Shown is the progression of intensities (relative units) of the 4326 Da (A), 6632 Da (B) and 133977 Da (C) peaks of the mass profiles over time. W0, W12 and W24 correspond to duration of Etanercept treatment expressed in weeks. Samples exhibiting a significant difference for C (healthy controls) vs W0, W0 vs W12 and W0 vs W24 are shown. Horizontal lines correspond to the mean of the 10 samples for each condition. P-values were calculated using the non-parametric Mann-Whitney test when comparing C to W0 (unpaired data), and the non-parametric Wilcoxon signed-rank test when comparing W0 to W12, or W0 to W24 (paired data). *Statistically significant difference between C and W0. **Statistically significant difference between W0 and W12, or between W0 and W24. The 4.3 and 134 kDa masses were detected using fraction 2, and the 6.6 kDa mass was detected using fraction 4. <t>ProteinChip®,</t> matrix and laser intensity conditions are detailed in Table 2.
    Proteinchip® Seldi Reader Pcs4000 Ms Tof Enterprise, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pm29778662-75-6-12?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    proteinchip® seldi reader pcs4000 ms-tof enterprise - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    seldi proteinchip reader  (Bio-Rad)
    90
    Bio-Rad seldi proteinchip reader
    Progression of specific intensity peaks within mass profiles during Etanercept treatment. Shown is the progression of intensities (relative units) of the 4326 Da (A), 6632 Da (B) and 133977 Da (C) peaks of the mass profiles over time. W0, W12 and W24 correspond to duration of Etanercept treatment expressed in weeks. Samples exhibiting a significant difference for C (healthy controls) vs W0, W0 vs W12 and W0 vs W24 are shown. Horizontal lines correspond to the mean of the 10 samples for each condition. P-values were calculated using the non-parametric Mann-Whitney test when comparing C to W0 (unpaired data), and the non-parametric Wilcoxon signed-rank test when comparing W0 to W12, or W0 to W24 (paired data). *Statistically significant difference between C and W0. **Statistically significant difference between W0 and W12, or between W0 and W24. The 4.3 and 134 kDa masses were detected using fraction 2, and the 6.6 kDa mass was detected using fraction 4. <t>ProteinChip®,</t> matrix and laser intensity conditions are detailed in Table 2.
    Seldi Proteinchip Reader, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/us09598437-154-11-14?v=Bio-Rad
    Average 90 stars, based on 1 article reviews
    seldi proteinchip reader - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    seldi personal edition proteinchip reader  (Bio-Rad)
    93
    Bio-Rad seldi personal edition proteinchip reader
    Progression of specific intensity peaks within mass profiles during Etanercept treatment. Shown is the progression of intensities (relative units) of the 4326 Da (A), 6632 Da (B) and 133977 Da (C) peaks of the mass profiles over time. W0, W12 and W24 correspond to duration of Etanercept treatment expressed in weeks. Samples exhibiting a significant difference for C (healthy controls) vs W0, W0 vs W12 and W0 vs W24 are shown. Horizontal lines correspond to the mean of the 10 samples for each condition. P-values were calculated using the non-parametric Mann-Whitney test when comparing C to W0 (unpaired data), and the non-parametric Wilcoxon signed-rank test when comparing W0 to W12, or W0 to W24 (paired data). *Statistically significant difference between C and W0. **Statistically significant difference between W0 and W12, or between W0 and W24. The 4.3 and 134 kDa masses were detected using fraction 2, and the 6.6 kDa mass was detected using fraction 4. <t>ProteinChip®,</t> matrix and laser intensity conditions are detailed in Table 2.
    Seldi Personal Edition Proteinchip Reader, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/proteinchip+seldi+reader/pmc04988630__pntd__0004926__s003-762-23-28?v=Bio-Rad
    Average 93 stars, based on 1 article reviews
    seldi personal edition proteinchip reader - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Comparison of human tear proteome studies concerning patients affected by ocular diseases

    Journal: Mass Spectrometry Reviews

    Article Title: Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery

    doi: 10.1002/mas.21691

    Figure Lengend Snippet: Comparison of human tear proteome studies concerning patients affected by ocular diseases

    Article Snippet: Grus et al. ( ) , DED , Single subject, 1 take , STS , 20 μl , ProteinChip Array , None , None , None , None , SELDI‐TOF Ciphergen ProteinChip Reader PBS II (Ciphergen Biosystems) , Full scan , Ciphergen Express Data Manager , N/D.

    Techniques: Software, Biomarker Assay

    Comparison of human tear proteome studies concerning patients affected by systemic diseases

    Journal: Mass Spectrometry Reviews

    Article Title: Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery

    doi: 10.1002/mas.21691

    Figure Lengend Snippet: Comparison of human tear proteome studies concerning patients affected by systemic diseases

    Article Snippet: Grus et al. ( ) , DED , Single subject, 1 take , STS , 20 μl , ProteinChip Array , None , None , None , None , SELDI‐TOF Ciphergen ProteinChip Reader PBS II (Ciphergen Biosystems) , Full scan , Ciphergen Express Data Manager , N/D.

    Techniques: Software

    Comparison of human tear proteome studies concerning patients affected by ocular diseases

    Journal: Mass Spectrometry Reviews

    Article Title: Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery

    doi: 10.1002/mas.21691

    Figure Lengend Snippet: Comparison of human tear proteome studies concerning patients affected by ocular diseases

    Article Snippet: Tomosugi et al. ( ) , DED, SS , Single subject, 1 take , STS , 24 μl , ProteinChip Array , None , None , None , None , SELDI‐TOF Ciphergen ProteinChip Reader PBS II (Ciphergen Biosystems) , Full scan , Biomarker Wizard , 56.

    Techniques: Software, Biomarker Assay

    Comparison of human tear proteome studies concerning patients affected by systemic diseases

    Journal: Mass Spectrometry Reviews

    Article Title: Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery

    doi: 10.1002/mas.21691

    Figure Lengend Snippet: Comparison of human tear proteome studies concerning patients affected by systemic diseases

    Article Snippet: Tomosugi et al. ( ) , DED, SS , Single subject, 1 take , STS , 24 μl , ProteinChip Array , None , None , None , None , SELDI‐TOF Ciphergen ProteinChip Reader PBS II (Ciphergen Biosystems) , Full scan , Biomarker Wizard , 56.

    Techniques: Software

    Progression of specific intensity peaks within mass profiles during Etanercept treatment. Shown is the progression of intensities (relative units) of the 4326 Da (A), 6632 Da (B) and 133977 Da (C) peaks of the mass profiles over time. W0, W12 and W24 correspond to duration of Etanercept treatment expressed in weeks. Samples exhibiting a significant difference for C (healthy controls) vs W0, W0 vs W12 and W0 vs W24 are shown. Horizontal lines correspond to the mean of the 10 samples for each condition. P-values were calculated using the non-parametric Mann-Whitney test when comparing C to W0 (unpaired data), and the non-parametric Wilcoxon signed-rank test when comparing W0 to W12, or W0 to W24 (paired data). *Statistically significant difference between C and W0. **Statistically significant difference between W0 and W12, or between W0 and W24. The 4.3 and 134 kDa masses were detected using fraction 2, and the 6.6 kDa mass was detected using fraction 4. ProteinChip®, matrix and laser intensity conditions are detailed in Table 2.

    Journal: American Journal of Translational Research

    Article Title: Targeting TNFα in severe psoriasis-mass spectrometry reveals a time-dependent specific inhibition of Factor H in responding patients

    doi:

    Figure Lengend Snippet: Progression of specific intensity peaks within mass profiles during Etanercept treatment. Shown is the progression of intensities (relative units) of the 4326 Da (A), 6632 Da (B) and 133977 Da (C) peaks of the mass profiles over time. W0, W12 and W24 correspond to duration of Etanercept treatment expressed in weeks. Samples exhibiting a significant difference for C (healthy controls) vs W0, W0 vs W12 and W0 vs W24 are shown. Horizontal lines correspond to the mean of the 10 samples for each condition. P-values were calculated using the non-parametric Mann-Whitney test when comparing C to W0 (unpaired data), and the non-parametric Wilcoxon signed-rank test when comparing W0 to W12, or W0 to W24 (paired data). *Statistically significant difference between C and W0. **Statistically significant difference between W0 and W12, or between W0 and W24. The 4.3 and 134 kDa masses were detected using fraction 2, and the 6.6 kDa mass was detected using fraction 4. ProteinChip®, matrix and laser intensity conditions are detailed in Table 2.

    Article Snippet: ProteinChip®-captured proteins were detected using a ProteinChip® SELDI-TOF reader PCS4000 MS-TOF Enterprise (Bio-Rad).

    Techniques: MANN-WHITNEY